Mohindru Mani insider trades
Mohindru Mani has filed 13 Form 4s with the SEC that we hold, for Cardiff Oncology, Inc. (CRDF) (Chief Executive Officer, Director) and CytomX Therapeutics, Inc. (CTMX) (Director). Across all of them we count 2 purchases worth $79.9K and 0 sales worth $0 reported on Form 4. In the last 12 months: 2 purchases ($79.9K) and 0 sales ($0). The largest single trade was a purchase of 34,364 shares of Cardiff Oncology, Inc. worth $50.0K, dated 2026-07-14. The first filing on our record is dated 2022-03-10 and the latest 2026-07-16.
Cardiff Oncology, Inc. (CRDF)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-06-18 | P, purchase reported on Form 4 | 24,703 | $29.9K | 2026-06-22 |
| 2026-07-14 | P, purchase reported on Form 4 | 34,364 | $50.0K | 2026-07-16 |
CytomX Therapeutics, Inc. (CTMX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1664708) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms